Optimal conditions for determining the mitogenic activity of platelet growth factor in a homologous System (human palmar fascia fibroblasts/human platelet growth factor) were established. With the aid of this System it was possible to test the active fraction from crude platelet extract following affinity chromatography on heparin-Sepharose, chromatofocusing and molecular sieve filtration. This fraction has an isoelectric point of pH >9 with a molecular mass of about 12000 daltons and reacts with ß-thromboglobulin antiserum.
Introduction
The observation that serum, but not plasma, promotes the growth of fibroblasts in vitro (1) led to the discovery of various factors that stimulate cell growth (2) . The major component of mitogenic activity in serum proved to be a factor originating from
Hossler & Castor (8) , who found that plasma from patients with rheumatoid arthritis or lupus erythematosus has higher levels of a connective-tissue stimulating factor derived from platelets than healthy controls (connective-tissue activating peptide III). Myers & Christine (9) demonstrated elevated concentrations of this factor in the synovia of patients with inflammatory arthritic diseases. Weissbarth et al. (10) reported the induction of platelet release by sera from patients with rheumatoid arthritis.
It is difficult to make unambiguous Statements, because the platelet growth factors described by several authors in the literature differ in structure and physical properties. Thus "platelet-derived growth factor" (11, 12, 13) with a relative molecular mass of 27000-35000, "human platelet basic protein" (14) with a relative molecular mass of 10000-15000, "connective-tissue activating peptide III" (15) and "low-affinity platelet factor 4" (16) both with a relative molecular mass of 9300 have all been described äs platelet-derived factors with mitogenic activity. Immunologically, there is no distinction between platelet basic protein, connective-tissue activating peptide III/low affinity platelet factor 4 and the socalled packing protein of the platelets, ß.-thromboglobulin, which has no stimulatory activity. The objective of the work under review was to isolate the platelet growth factor or factors with simultaneous Separation of immunologically identical but inactive factors, to obtain clues äs to the identity of the various factors described in the literature, and to devise a test for proliferation Stimulation, in order to determine mitogenic activity. A further aim was to ascertain the extent to which the proliferation-promoting effect is associated with metabolic stimulating properties.
Isolation of platelet growth factor
The crude platelet extract was heated for 10 min at 100 °C. Precipitated protein was removed by centrifugation at 5000g, and the clear supernatant was fractionated on Sephadex G 75 (column 75 x 2.5 cim, eluant: 0.05 mol/1 tris -0.15 mol/1 NaCl, pH 7.8, elution speed 10 ml/h) into molecular moieties greater than and smaller than 60000 dalton. The low-mdlecular portion was applied to a heparin-Sepharose column (12 x l cm). After washing with 0.05 rriol/l tris -0.15 mol/I NaCI, pH 7.8, the growth-stimulating fraction was eluted with 0.05 mol/1 tris -0.5 mol/I NaCl, pH 7.8, dialysed against 0.05 mol/1 tris ^0.15 mol/1 NaCl, pH 7.8, and again purified over heparin-Sepharose äs above.
Isoelectric focusing for Separation of platelet growth factors
The material purified over heparin-Sepharose was fractionated by chromatofocusing on PBE 94 (Pharmacia) polybuffer exchanger pH 9.4 (column: 25 x l cm) with polybuffer 96 (Pharmacia) pH 6.0 at an elution speed of 6 ml/h. For determining the mitoĝ enic activity of the fractipns A (pl > 9.0), B (pl 8.9-7.6) and C (pl 7.5^6.5), these were again subjected to affinity chromatography on heparin-Sepharose, after which the purified fractions were used in the proliferation test.
Molecular sieve Separation of the factors
Molecular sieve Separation of the mitogenic fraction qbtained after chromatofocusing was performed on a Sephadex G 75 column (120 X 1.2 cm, eluant: Dulbecco's phosphate buffer pH 7.0, elution speed 3.1 ml/h). Calibräted proteins from Boehringer, Mannheim served äs markers (cytochrome c: relative molecular mass 12500, chymotrypsin: relative molecular mass 25000, albumin from chicken eggs: relative molecular mass 45000, ferritin: relative molecular mass 450000).
Inhibition of proteolysis of platelet growth factor
A crude platelet extract obtained by repeated freezing and thawing without the addition of protease inhibitors was separated into three portions (A, B, C). PortioruA »was incubated for 2 h at 4 °C, portion B for 2 h at 37 °C and portion C for 2 h at 37 °C with the addition of protease inhibitors (see above). Each sölutiön was heated for 10 min to 100 °C and centrifuged for 60 min at 5000 g. Following affinity chromatography of the supernatant on heparinSepharose, mitogenic activity was determined in the proliferation test.
ß-Thromboglobulin radioimmunoassay
The radioimmunoassay was performed with the IM 88 ß-throfnboglobulin RIA kit (Amersham/Buchler).
Materials and Methods
Crude platelet extract Fresh donor citrate blood (100-500 ml) was centrifuged for 10 min at 100g. The supernatant was separated and centrifuged fqr 10 min at 1000g. The platelet Sediment was washed twice, each time with a mixture consisting of 8 parts phosphate buffer (0.1 mol/1 NaCl, 2.68 mmol/1 KC1, 6 mmol/1 Na 2 HPO 4 x 2H 2 O, 4 mmol/1 KH 2 PO 4 ) and 2 parts citrate sölutiön (0.076 mol/1 citric acid, 0.15 mol/1 Na-citrate) pH 6.8 and centrifuged for 10 min at 1000 g. The platelets were then suspended in 0.05 mol/l tris buffer, containing 0.15 mol/1 NaCl (pH 7.8) and protease inhibitors (0.1 mol/1 6-aminocaproic acid, 0.01 mol/1 EDTA, 5 mmol/1 benzamidine hydrochloride hydrate, 0.3 mmol/1 N-acetylcysteine). The cells were disrupted by means of fourfold deep-freezing and thawing, and the crude platelet extract was separated from cellular debris by centrifugation for 60min at 5000g and 4°C.
Cell count
The cell numbers were determined 40 h after factor applieation äs described previously (18) .
Proliferation test
Mitogenic activity was determined on the basis of [ replicate determinations, 0.3 ml of a mixture consisting of 10 parts of the fraction to be tested (dialysed against PBS) or PBS äs a control, 85 parts medium and 5 parts PCS were then added to the culture. Fibroblasts from human palmar fascia of the second and third subculture were seeded in 8 cm 2 plastic culture dishes. After 24 h, 50 g of ascorbate per ml of medium was added for determination of collagen synthesis. Forty eight hours after inoculation the medium was sucked off and the cell colonies were washed with phosphate buffer (PBS), pH 7.0. To the culture was then added 1.5 ml of test mixture (89 parts medium, l part foetal calf serum, and either 10 parts of the fraction to be tested (dialysed against PBS)), or of PBS to act äs a eontrol. For determination of glycosaminoglycan synthesis sulphate-free medium had to be used. After an incubation period of 24h, 121 kBq of the tracer substance 
Results
A proliferation test, operating in a homölogous systerh (human platelet factor/humäri palmar fascia fibroblasts), was developed for quantifying mitogenic activity. The effects were studied of varying the concentration of foetal calf serum ( fig. 1) , the cell density of the cultures ( fig. 2 ), and the time at which the labeled precursor [ 3 H]thymidine was added after the factor had begun to exert an effect on the cells ( fig. 3) . In thte way, accelerated rates for [ With the help of the proliferation test Isolation of the platelet growth factor was pursued. By repeated deep-freezing and rethawing, using protease inhibitors and molecular sieve filtration followed by affinity chromatography on heparin-Sepharose, it was possible to obtain a platelet fraction from fresh citrate blood that had a high concentration of -thromboglobulin immunoreactive material. This fraction exhibited marked mitogenic activity in the proliferation test (tab. 1). The addition of protease inhibitors proved essential for the preservation of the mitogenic activity of the preparation ( fig. 5) Chromatofocusing of immunologically identical plat elet factors was undertaken to separate the substances on the basis of their diffefent isoelectric points. Fractionation into 3 pl ranges A: >9 (platelet basic protein), B: 8.9-7.6 (connective tiss e activating peptide/low affinity platelet factor 4) and C: 7.5-6.5 ( -thromboglobulin) yielded a fraction at pl >9 that was also immunologically identical to -thromboglobulin. Unlike the other fra^tions, however, it retained mitogenic activity in toto ( fig. 6) The isolated growth factor exhibited mitogenic properties in the proliferation test. Thus the addition of 350 ng of platelet factor per test preparation leads to about a seven-fold increase in DNA synthesis äs compared to the control value. Moreover, the factor also demonstrates an ability, although not äs pronounced, to stimulate collagen and glycosaminoglycan metabolism. 
Discussion
Several authors have described mitogenic factors in platelets that are released during blood coagulation or are poured into the bloodstream from cc-granula of the platelets in a release reaction. The methods employed to isolate these factors from platelets partly determine the definition and properties of the factors themselves.
As the results show, we were able to demonstrate a mitogenic factor in crude platelet extracts. The factor yields positive results in the ß-thromboglobulin radioimmunoassay and exhibits mitogenic activity in the proliferation test. The addition ofprotease inhibitors was essential for obtaining the mitogenic compound. In the absence of these inhibitors, the factor is degraded by cell or tissue proteases to ß-thromboglobulin, which is inactive äs a stimulator. A similar degradation of connective tissue activating peptide III has been discussed by Castor (22) . In vivo, especially in plasma, the proteases appear to function by limiting the effect of the platelet growth factor, thereby counteracting any excess release of the factor.
With the aid of chroniatofocusing it was possible to separate the growth stimulating fraction from immunologically identical factors on the basis of their different isoelectric points (pl) -platelet basic protein (pl: 10.0), connective tissue activating peptide/low affinity platelet factor 4 (pl: 8.0-8.5) and ß-thromboglobulin (pl: 7-0). It was shown that only the fraction having an isoelectric point of greater than 9 exhibits mitogenic activity. The fraction containing connective tissue activating peptide III exhibited no activity in the proliferation test; this observation disagrees with the results of Castor. The discrepancy could be accounted for if we assume that the method used by Castor probably did not achieve complete Separation of platelet basic protein and connective tissue activating peptide III. A relative molecular mass of about 12500 was determined for the isolated growth factor. At the same time the substance proved to be immunologically identical to ß-thromboglobulin. These results agree with the data published by Paul et al. (14) for the human platelet basic protein.
In the relative molecular mass ränge of about 30000, in which platelet derived growth factor (pl: 10.0) was expected, (according to Heldin et al. (23) this factor does not cross-react with ß-thromboglobulin antiserum), we observed no increase in the rate of [ 3 H]thymidine incorporation. The reason for this may lie in the substantially lower initial quantities of these substance in the crude platelet extract (200 times less), äs measured by ß-thromboglobulin immunoreactive material. Further, inactivation of platelet-derived growth factor during the chromatofocusing step must be considered. This, however, requires further investigation.
monkey smooth muscle cells by platelet growth factor. Castor et al. (25) observed increased release of acidic glycosaminoglycans into the culture medium of human fibroblasts following the addition of platelet factor. § f From the above results the following picture emerges. Human platelet basic protein with a relative molecular mass of about 12000 represents the active growth factor from platelets. This compound is degraded by the cleavage of oligopeptides to form connective tissue activating peptide/low affinity platelet factor 4 and theii ß-thromboglobulin, with the immunological determinants remaining intäct.
The above described proliferation test was based not on the 3T3 mouse cells widely cited in the literature for determination of mitogenic activity, but rather on a homologous System (human fibrpblasts/human platelet factor). For improved reproducibility and in order to avoid dedifferentiation phenomena äs far äs possible, it is advisable tö work with only a single cell line in the second to fourth subcultures. There seems to be no need for addition of a 'prpgr ession factor' (26) . Obviously the calf serum used in the culture media provides sufficient somatomedin activity to enable the fibroblasts to answer the Stimulation by the platelet growth factor (competence factor).
In this System the Variation coefficient (CV) is less than 10%. Comparisons with experiments using various cell lines are not possible due to the high biological variance involved. Experiments with permanent lines of human fibroblasts äs test cells are now in progress.
In addition to the use of the test for characterizing the mitogenic activity of fractions and factors isolated from platelets, the System also permitted the direct assay of the mitogenic activity of factors re-, leased from platelets in biological material, following their isolation by heparin-Sepharose chromatography. This is all the more important, äs the elevated ß-thromboglobulin levels (plasma/synovia) reported by Mac Carter (8) and Myers & Christine (9) in rheumatic diseases provide no Information on the quantity of active growth factor. The ß-thromboglobülin radioimmunoassay represents only a very sensitive method for detecting enhanced thrombocytic function.
Besides marked mitogenic properties, the isolaited platelet growth factor also stimulated glycosaminoglycan and Collagen synthesis. This coincides with the findings of other authors. Thus Burke & ROSS (24) described Stimulation of collagen synthesis in
